Skip to main navigation Skip to search Skip to main content

The Mechanism of Adjuvanticity of Aluminium-Containing Formulas

  • K Fierens
  • , Mirjam Kool

Research output: Contribution to journal › Article › Academic › peer-review

13 Citations (Scopus)

Abstract

Vaccinations have been given to people for at least 100 years of which 80 years formulated in adjuvants. Currently, aluminium-containing formulas and the oil-based substance called MF59 are the two adjuvants licensed for clinical use. Despite the massive use of aluminium adjuvant, its mechanism of action has been only recently addressed. In this review, we will discuss both the cellular and molecular mode of action of aluminium-containing adjuvants.
Original languageUndefined/Unknown
Pages (from-to)2305-2313
Number of pages9
JournalCurrent Pharmaceutical Design
Volume18
Issue number16
DOIs
Publication statusPublished - 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research programs

  • EMC MM-04-42-02

Cite this